PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.\', \'Department of Chemistry, Columbia University, New York, NY, 10027, USA.\', \'Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.\', \'Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA. dj222@columbia.edu.\', \'Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA. dj222@columbia.edu.\', \'Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, 10032, USA. dj222@columbia.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-020-73641-9
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33024223
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33024223>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33024223>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all